Minerva Neurosciences (NERV) Intangibles (2013 - 2024)
Minerva Neurosciences (NERV) reported Intangibles of $4257.0 for Q2 2024, down 85.71% on a YoY basis from $29797.0 in Q3 2023, and down 60.0% quarter-over-quarter from $10642.0 in Q1 2024.
Minerva Neurosciences (NERV) Intangibles (2013 - 2024) Analysis & Trends
Minerva Neurosciences has reported Intangibles for 12 years, with the latest figure at $4257.0 in Q2 2024.
- For the quarter ending Q2 2024, Intangibles fell 85.71% year-over-year to $4257.0; the trailing twelve-month figure through Jun 2024 stood at $4257.0 (down 85.71% YoY), and the FY2023 full-year result was $17027.0, down 60.0% from the prior year.
- Intangibles for Q2 2024 stood at $4257.0, down from $10642.0 in the prior quarter.
- The five-year high for Intangibles was $15.2 million in Q1 2020, with the low at $4257.0 in Q2 2024.
- Historically, Intangibles has averaged $5.9 million across 5 years, with a median of $51080.0 in 2021.
- Annual changes were most pronounced in 2020 — Intangibles changed 0.0% — and 2022, when it tumbled 99.68%.
- Minerva Neurosciences' Intangibles stood at $15.2 million in 2020, then slumped by 99.66% to $51080.0 in 2021, then decreased by 16.67% to $42567.0 in 2022, then slumped by 60.0% to $17027.0 in 2023, then sank by 75.0% to $4257.0 in 2024.
- The last three Intangibles figures came in at $4257.0 (Q2 2024), $10642.0 (Q1 2024), and $17027.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Minerva Neurosciences | 197.55 Mn | 197.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4,257.00 |
| Mar 31, 2024 | 10,642.00 |
| Dec 31, 2023 | 17,027.00 |
| Sep 30, 2023 | 23,412.00 |
| Jun 30, 2023 | 29,797.00 |
| Mar 31, 2023 | 36,182.00 |
| Dec 31, 2022 | 42,567.00 |
| Sep 30, 2022 | 48,952.00 |
| Jun 30, 2022 | 51,080.00 |
| Mar 31, 2022 | 51,080.00 |
| Dec 31, 2021 | 51,080.00 |
| Sep 30, 2021 | 15.20 Mn |
| Jun 30, 2021 | 15.20 Mn |
| Mar 31, 2021 | 15.20 Mn |
| Dec 31, 2020 | 15.20 Mn |
| Sep 30, 2020 | 15.20 Mn |
| Jun 30, 2020 | 15.20 Mn |
| Mar 31, 2020 | 15.20 Mn |
| Dec 31, 2019 | 15.20 Mn |
| Sep 30, 2019 | 34.20 Mn |